Skip to content

Immune Responses in Severe COVID-19 Patients

On Demand

Speaker

dexi-chen

Dexi Chen

Professor and Director

In this webinar, you will discover: 

  • How the immune response in severe COVID-19 patients was assessed.
  • The change in the T-cell population for patients suffering from severe COVID-19.
  • Changes in expression of genes related to T-cell activation and differentiation.
  • How this information may help researchers understand the immune response to COVID-19 and inform treatment strategies.

The global patient mortality rate of COVID-19 has been 3-4% of confirmed cases since the outbreak first began. The response of the immune system may play a critical role in the disease progression, severity, and mortality of COVID-19, with some studies showing decreased T cells and natural killer cells in patients infected with SARS-CoV-2, the virus responsible for COVID-19.

Professor Dexi Chen, the Director of the Beijing Institute of Hepatology,  investigated the immune system of patients suffering from severe COVID-19. The study uncovered a decreased proportion of T-cells and downregulation of genes related to T-cell activation and differentiation in severe COVID-19 patients.

This information may help researchers understand the immune response to COVID-19 and inform treatment strategies for the disease.

For Research Use Only. Not For Use In Diagnostic Procedures.

All registrants will receive a link to watch the recorded replay.

Webinar brought to you by


Enter your details to attend this webinar on demand

All Bitesize Bio emails contain an unsubscribe link.
You can review our privacy policy, cookie policy and terms and conditions online.

Share this to your network:
Scroll To Top